# MilliporeSigma invests $65M in HPAPI and ADC manufacturing expansion

MilliporeSigma is investing $65 million to expand its high-potent active pharmaceutical ingredient and antibody-drug conjugate manufacturing capabilities at its facility near Madison, Wisconsin, adding approximately 50 jobs.

- Type: Expansion
- Announced: 2020-09-09
- Where: Madison, Wisconsin, United States
- Value: $65.0M
- Jobs: 50
- Starts operating: Jul 2022
- Status: announced
- Capacity: 70,000 square feet
- Products: high-potent active pharmaceutical ingredients, antibody-drug conjugates
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [MilliporeSigma](https://endata.com/companies/7341.md)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/milliporesigma-announces-65-million-antibody-drug-conjugate-manufacturing-expansion-301125752.html), 2020-09-09: "MilliporeSigma today announced a $65 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.